An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

M002 PRIA Fee Category

PRIA 4 Fee Determination Decision Tree:

Complete Study Requiring Human Studies Review Board

Below is the fee for your selected Fee Category for Fiscal Years 2020-2021

Action Code Description FY'20-FY'21 Fee Decision Time (months)
M002 Completed study requiring Human Studies Review Board review as defined in 40 CFR Part 26 in support of an active ingredient (4) $8,335 9

Do you plan to request either of the following types of waivers?

Waiver Pay Amount
50% waiver You pay ---->>>>> $4,168
75% waiver You pay ---->>>>> $2,084

To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.

How to submit your application directly to EPA.

Action Code Interpretation

This category includes completed studies submitted to EPA, in support of an active ingredient, which report research involving intentional exposure of a human subject, as those terms are defined in 40 CFR parts 26.1102(d), (e), and (i). Worker exposure studies and insect repellant efficacy studies are the most common types of studies submitted to OPP that may meet the regulatory definition of “research involving intentional exposure.”

A study conducted to generate data to populate a generic database such as the Agricultural Handler Exposure Database (AHED) or the Biocide Handler Exposure Database (BHED) will not be considered a PRIA action because the data are not intended to be used to support a particular active ingredient.

EPA will review both the scientific and ethical aspects of completed studies covered by this category. EPA will submit its review of the completed study, together with the available supporting materials, to the Human Studies Review Board (HSRB). The HSRB will provide comment on both the scientific and ethical aspects of the study. EPA will consider the HSRB’s advice in determining whether to rely on the study.

Any other covered application that is associated with and dependent upon the HSRB review will be subject to its separate fee. The decision review time for the associated action will run concurrently with that of the HSRB review but will end at the date of the latest review time.

Go to the start of the Decision Tree